Skip to main content

Table 1 Patient epidemiological data, medical disorders and treatments

From: Perioperative complications after surgical treatment in degenerative adult de novo scoliosis

  

1

2

3

4

5

6

7

  

Total

Early complications

(< 30 d)

Late complications

(> 30 d)

No complications

p-value (3–2)

p-value (4–2)

p-value (4–3)

  

n = 92

%

n = 23

%

n = 49

%

n = 20

%

   
 

Age (years)

67.2 ± 7.9

69.1 ± 8.3

67.2 ± 7.4

65.3 ± 8.5

0.34

0.14

0.35

 

BMI (kg/m^2)

26.6 ± 3.4

27.0 ± 3.2

26.8 ± 3.2

25.9 ± 4.1

0.90

0.38

0.33

Gender

Male

28

30.4

7

30.4

13

26.5

8

40.0

0.73

0.52

0.28

Female

64

69.6

16

69.5

36

73.5

12

60.0

0.73

0.52

0.28

ASA class

1

1

1.0

0

0.0

0

0.0

1

5.0

–

0.29

0.12

2

62

67.3

13

56.5

35

71.4

14

70.0

0.22

0.37

0.91

3

29

31.5

10

43.4

14

28.5

5

25.0

0.22

0.21

0.77

4

0

0.0

0

0.0

0

0.0

0

0.0

–

–

–

 

Obesity

20

21.7

4

17.3

11

22.4

5

25.0

0.63

0.55

0.82

 

Smoker

26

31.7

6

30.0

12

28.5

8

40.0

0.91

0.52

0.38

 

Type 1 Diabetes

8

8.9

4

8.6

4

8.6

0

0.0

0.29

0.05

0.18

 

Type 2 Diabetes

11

11.5

5

12.7

6

12.7

0

0.0

0.26

< 0.05

0.10

 

COPD

15

16.4

6

26.0

7

14.5

2

10.0

0.25

0.18

0.62

 

Osteoporosis

23

25.0

6

26.0

14

28.5

3

15.0

0.83

0.38

0.24

 

Neurological Disease

4

4.3

0

0.0

4

8.1

0

0.0

0.16

–

0.19

 

Hypertension

34

36.9

11

47.8

16

32.6

7

35.0

0.22

0.41

0.85

 

PM

5

5.4

3

13.0

2

4.0

0

0.0

0.17

0.10

0.37

 

CA

19

22.6

9

40.9

9

21.4

1

5.0

0.10

< 0.05

0.10

 

RA

7

7.6

2

8.6

4

8.1

1

5.0

0.94

0.64

0.65

 

Cortisone

6

6.5

2

4.0

2

4.0

2

10.0

0.43

0.89

0.35

 

ASS

7

7.6

1

10.2

5

10.2

1

5.0

0.41

0.92

0.49

 

Coumarin derivative

8

8.6

4

17.3

2

4.0

2

10.0

0.06

0.50

0.35

  1. Abbreviations: BMI body mass index, ASA class American Society of Anesthesiologists, COPD chronic obstructive pulmonary disease, PM pacemaker, CA cardiac arrhythmias, RA rheumatoid arthritis, ASS acetylsalicylic acid, coumarin derivative – phenprocoumon. Statistical analyses regarding p-values were performed between the three columns/groups, i.e. early complications (2), late complications (3) and no complications (4); see superscripted numbers (significance at p < 0.05 or at p < 0.01)